Included trials with full Time to collect data | ||||||||
---|---|---|---|---|---|---|---|---|
Number of trials | Number of primary outcomes data points | Median total trial time to collect for primary outcomes (minutes) [min–max] | Primary outcome IQR (minutes) [lower limit–upper limit] | Number of secondary outcomes data points | Median total trial time to collect for secondary outcomes (minutes) [min–max] | Secondary outcome IQR (minutes) [lower limit–upper limit] | Median primary to secondary total Time to collect ratio | |
All trials | 134 | 134 | 3367.5 [0.0–644,800.0] | 13,613.3 [− 19,089.38–35,363.63] | 134 | 11,440.0 [0.0–81,409,972.0] | 37,057.5 [− 52,586.25–95,643.8] | 1: 3.0 |
Phase III | 100 | 100 | 3225.0 [0.0–644,800.0] | 7684.0 [− 10,218.5–20,517.5] | 134 | 9984.00 [0.0–81,409,972.0] | 28,400.5 [− 39,650.8–73,951.3] | 1: 3.1 |
Core outcome set | 17 | 17 | 2500.0 [0.0–120,285.0] | 10,395.0 [− 14,890.5–26,689.5] | 17 | 9475.0 [90.0–75,600.0] | 19,013.0 [− 26,236.5–49,815.5] | 1: 3.4 |
Public health | 17 | 17 | 21,231.5 [410.0–363,168.0] | 44,916.0 [− 64,365.0–115,299.0] | 17 | 30,250.0 [546.0–451,710.0] | 98,208.0 [− 139,324.0–253,508.0] | 1: 2.2 |